Skip to content

CATALENT PHARMA SOLUTIONS, INC.

CIK 0001416083

← back to feed
Revenue (TTM)
$1.71B
+6.2% YoY Q3 Apr 2014
Net Income (TTM)
−$29.8M
−15.6% YoY Q3 Apr 2014
EPS Diluted (TTM)
—
Q3 Apr 2014
Gross Margin
31.9%
Q3 Apr 2014
Operating Margin
11.0%
Q3 Apr 2014
Net Margin
-1.7%
Q3 Apr 2014
Free Cash Flow (TTM)
−$23.6M
Q3 Apr 2014
Cash
$55.7M
Q3 Apr 2014
Total Debt
$2.7B
Q3 Apr 2014
Shares Outstanding
100 sh
Q3 Apr 2014

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings